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Mechanisms of polymorphonuclear leukocyte mediated peritoneal me-
sothelial cell injury. To determine the susceptibility of human peritoneal
mesothelial cells to injury mediated by activated polymorphonuclear
leukocytes (PMNs), we exposed cultured human peritoneal mesothelial
cells to 1250, 2500, 3750, and 5000 PMNs/mm3 activated with 50 ng/ml
phorbol myristate acetate (PMA) or with iO— FMLP/cytochalasin B for
one to five hours. PMN adhesion to mesothelial cells was determined with
radiolabeled PMNs. Mesothelial cell injury was determined in five differ-
ent cell lines by measuring ATP depletion and 51chromium release. In
each mesothelial cell line, PMN adhesion was significantly (P < 0.001)
increased when PMNs were activated; 64 1.0 to 92.5 7.0% of the
activated PMNs were adherent to mesothelial cells compared to 6 1.8 to
27 2.4% of resting PMNs. Mesothelial cells responded to PMN
mediated injury with a fall in ATP levels and 51chromium release that was
significant (P < 0.05) by three to four hours. At five hours, ATP levels
were markedly depressed to 5 to 41% of control values. Increasing
concentrations of activated PMNs caused significantly (P < 0.05) greater
mesothelial cell injury as determined by ATP depletion and 51chromium
release. PMN adhesion, ATP depletion and 5chromium release were
significantly (P < 0.01) prevented by an anti-CD18 monoclonal antibody
that inhibits the CD11/CD18 adhesion molecule complex on PMNs.
Similar injury and protection from injury was demonstrated when me-
sothelial cells were exposed to PMNs activated with FMLP/cytochalasin B.
Immunohistochemical studies demonstrated that the cultured mesothelial
cells express intracellular adhesion molecule I (ICAM-1) and FAB
fragments of a tnonoclonal anti-ICAM-1 antibody partially reduced
adhesion of activated PMNs to mesothelial cells and slightly reduced
mesothelial cell injury. Staphylococcus aureus, Staphylococcus epidermi-
dis, alpha streptococci, and Pseudomonas aeruginosa at concentrations of
iO to iO bacteria/mi caused little to no ATP depletion or 51chromium
release. We conclude that activated PMNs adhere to human mesothelial
cells and induce mesothelial cell injury; such injury can be partially
reduced by blocking adhesion of activated PMNs to mesothelial cells.
Peritonitis results in an acute injury to the peritoneal mem-
brane that is characterized by increased solute clearance, en-
hanced glucose absorption and decreased net ultrafiltration due to
rapid dissipation of the osmotic gradient. In addition, protein
losses into dialysate are increased [1—2]. These changes are usually
reversible and return to normal over a period of days to weeks. In
animals with peritonitis, peritoneal clearance studies performed
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in conjunction with light, transmission and scanning electron
microscopy demonstrated that the alterations of membrane trans-
port were associated with marked structural alterations of me-
sothelial cells [2]. Polymorphonuclear leukocytes were adherent
to mesothelial cells that demonstrated morphologic alterations
including retraction with exposure of the underlying basement
membrane [2]. These studies suggest that peritoneal membrane
injury is the result of mesothelial cell injury from activated PMNs.
When activated by stimuli such as bacterial infection, immune
complexes, platelet activating factor, endotoxin, opsonized zymo-
san or phorbol esters, PMNs undergo a respiratory burst and take
up massive quantities of oxygen which is converted to reactive
oxygen molecules used for microbial killing [3—5]. Such reactive
oxygen molecules include superoxide anion (02 ), hydrogen
peroxide (H202), and hydroxyl radical (HO•). Mycloperoxidase
from activated PMNs converts hydrogen peroxide to hypochior-
ous acid which may react with amines to form chioramines; these
reactive oxygen metabolites are capable of oxidizing proteins and
membranes resulting in substantial tissue injury [3, 4]. In addition
to myeloperoxidase, activated PMNs also release a number of
protease enzymes which act in concert with reactive oxygen
molecules to create a microenvironment of injury mediated by
oxidants and proteolytic enzymes [3, 4]. This coordinated host
defense against invading microbes results in killing of the micro-
organism but initiates an inflammatory response that can result in
substantial tissue injury. Once generated, oxidants initiate several
metabolic alterations including activation of the glutathione redox
cycle, elevation of intracellular calcium, DNA damage, ATP and
NAD depletion, and morphologic alterations including cell de-
tachment and lytic injury [5—9]. In addition, oxidant injury results
in alterations in barrier function as demonstrated by increased
permeability of epithelial cell monolayers in vitro and leaky
capillaries in vivo [10, 11].
During peritonitis, mesothelial cells are exposed to proteolytic
enzymes and reactive oxygen molecules produced by activated
PMNs. To determine if mesothelial cells are susceptible to injury
mediated by activated PMNs as would occur during peritonitis, we
exposed mesothelial cells cultured from normal human omentum
to activated PMNs. In addition, we exposed mesothelial cells to
various concentrations of bacteria to determine if bacteria alone
were capable of inducing mesothelial cell injury. We demonstrate
that activated PMNs induce substantial mesothelial cell injury as
determined by ATP depletion, cell detachment and cell lysis.
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Mesothelial cell injury was associated with marked increased
adhesion of activated PMNs to mesothelial cells. In contrast,
concentrations of bacteria (Staphylococcus aureus, Staphylococ-
cus epidermidis, alpha streptococci, and Pseudomonas aerugi-
nosa) reported to occur during peritonitis resulted in little to no
ATP depletion, cell detachment or lytic injury. Finally, PMN
adhesion to mesothelial cells and PMN mediated mesothelial cell
injury could be significantly reduced by a monoclonal antibody to
CD11/CD18, a leukocyte adhesion molecule located on activated
PMNs, and partially prevented by blocking ICAM-1, a major
ligand for CD11/CD18, expressed on mesothelial cells.
Methods
Culture, identification and characterization of mesothelial cells
Mesothelial cells were cultured from human omentum col-
lected from patients undergoing elective abdominal surgery [12,
13]. Briefly, omentum was incubated at 37°C for 20 minutes in
PBS containing 0.125% trypsin, 0.01% EDTA and 5.5 mvi glu-
cose. The suspension was centrifuged for five minutes at 50 X g
and the omentum was discarded. The supernatant and cell pellet
were centrifuged for five minutes at 100 X g. The cell pellet was
resuspended in DME/Ham's F-12 medium (1:1) with 10 mM
HEPES, 100 t/ml penicillin and 10% fetal calf serum (FCS) and
plated onto gelatin coated 25 cm2 tissue culture flasks. Media
were replenished every 48 to 72 hours. When confluent, cells were
subcultured using PBS containing 0.125% trypsin, 0.01% EDTA,
5.5 mM glucose solution, washed and plated onto gelatin coated 25
cm2 flasks or 24 well plates. Experiments were performed in 24
well plates with cells in the first or second passage.
Cells were identified as mesothelial by their characteristic
polygonal appearance at confluence and by positive immunoflu-
orescent staining for cytokeratin and vimentin and negative
immunofluorescent staining for desmin and Factor VIII related
antigen. Staining for cytokeratin, vimentin, and desmin was done
with indirect immunofluorescence with monoclonal antibodies to
human cytokeratin, desmin and vimentin (Dakopatts, Bucks,
UK). The second antibody was fluorescein conjugated rabbit
anti-mouse IgG (ICN Immunobiologicals, Lisle, Illinois, USA).
Staining for Factor VIII related antigen was done with direct
immunofluorescence with a fluorescein conjugated antibody from
Atlantic Antibodies. Cells grown on plastic coverslips were fixed
in cold acetone and methanol (mixed 1:1) then incubated with the
monoclonal antibody in a humidified chamber for 45 minutes. The
coverslips were extensively washed in PBS with 1% albumin and
then incubated with the fluorescein conjugated antibody in a dark,
humidified chamber for 45 minutes. After washing in PBS with
1% albumin, the coverslips were mounted on a slide and exam-
ined with a Zeiss fluorescence microscope. To serve as a positive
control for Factor VIII related antigen, human umbilical vein
endothelial cells were also stained in an identical manner.
PMNs and bacteria
Human PMNs were obtained from heparinized blood of normal
volunteers by dextran sedimentation, Ficoll-Hypaque gradient
centrifugation, and hypotonic lysis of red cells [14]. Human PMNs
were suspended in Hanks Balanced Salt Solution (HBSS) buff-
ered with 10 mivi HEPES with 0.5% albumin and without serum at
concentrations of 1250, 2500, 3750, and 5000 per cubic millimeter
(concentrations commonly observed in clinical cases of peritoni-
tis). Similar concentrations of PMNs obtained from dialysate
during episodes of peritonitis have been shown to generate
reactive oxygen molecules [15]. Mesothelial cells were preindu-
bated for 10 minutes at 37°C in a 5% CO2 incubator with 400 il
of the PMN solution per well. Each well of a 24 well plate contains
approximately 200,000 mesothelial cells; thus, the approximate
PMN to mesothelial cell ratio was 2.5:1, 5.0:1, 7.5:1, and 10:1 for
1250, 2500, 3750, and 5,000 PMN/mm3, respectively. These are
similar concentrations and PMN to target cell ratios that have
been previously found to result in endothelial cell injury [16]. To
simulate the activation that is initiated by bacteria, PMNs were
activated with 50 ng/ml phorbol myristate acetate (PMA) or iO
FMLP with 5 g/ml cytochalasin B [17]. Staphylococcus aureus,
Staphylococcus epidermidis, alpha streptococci, and Pseudomo-
nas aeruginosa were isolated from dialysate from patients with
peritonitis. The bacteria were cultured and identified by standard
microbiological techniques. Before experiments, the bacteria were
cultured in Nutrient Broth (Oxoid Ltd.) for 24 hours, centrifuged,
washed and resuspended in HEPES buffered HBSS with 0.5%
albumin at concentrations of io, iOn, and io bacteria/ml. These
concentrations of bacteria are substantially higher than bacterial
concentrations previously reported to occur during peritonitis
[18]. Bacterial concentrations were estimated by measuring opti-
cal densities of bacterial dilutions at 540 nm in a PyeUnicam
Spectrophotometer. An absorbance per cm of 1,0 corresponds to
approximately 3 — 5 X iO colony forming U/ml [19, 20]. Bacterial
concentrations were confirmed by culture of diluted samples.
PMN adhesion
Several recent important studies have demonstrated a central
role for cell adhesion in mediating PMN induced injury [21—23].
To determine the role of PMN adhesion in mediating mesothelial
cell injury, PMN adhesion was determined with 51chromium
(51Cr) labeled PMNs. After isolation, PMNs were labeled with
51Cr by incubation with 0.5 mCi in 3 ml normal saline at room
temperature for 30 minutes; the PMNs were then washed three
times in normal saline to remove excess 51Cr. 51Cr labeled PMNs
were resuspended in HEPES buffered HBSS with 0.5% albumin
then preincubated with mesothelial cells for 10 minutes. After
preincubation, PMNs were activated with PMA or FMLP/cy-
tochalasin B and allowed to incubate at 37°C. At the appropriate
time period, the supernatant was removed and the monolayer was
gently washed once with an automatic pipetter that dispenses the
wash fluid with a constant gentle force. The monolayer with the
adherent radiolabeled PMNs was dissolved in 2.0% Triton,
counted in a Beckman gamma counter and the percent adherence
was calculated as the number of CPM in the cell fraction divided
by the CPM of the original PMN suspension.
ATP levels
In time course experiments, five mesothelial cell cultures (each
from a separate source) were exposed to 5000 PMNs/mm3 in
HEPES buffered HBSS with 0.5% albumin in 24 well plates at
37°C. In dose response experiments, the five mesothelial cell
cultures were exposed to 1250, 2500, 3750, or 5000 PMNs/mm3
(concentrations similar to that observed in peritonitis) for five
hours at 37°C. The PMNs were activated with 50 ng/ml PMA or
iO FMLP/cytochalasin B after a 10 minute preincubation with
mesothelial cells as described for the PMN adhesion experiments;
controls included mesothelial cells with buffer alone, mesothelial
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cells exposed to PMA or FMLP/cytochalasin B without PMNs and
mesothelial cells exposed to PMNs without PMA. ATP levels
were determined with luciferin-luciferase as previously described
[6, 7]. Cells were solubilized with 500 j.d 0.5% Triton X-100 and
acidified with 100 j.d 0.6 M perchioric acid and placed on ice. At
the time of assay, the cell suspension was diluted with 10 mM
potassium phosphate buffer containing 4 mtvt MgSO4 (pH 7.4);
500 d of this were added to 1 ml of 50 m sodium arsenate buffer
containing 20 mi MgSO4 (pH 7.4) to which 25 .d of 40 mg/mI
luciferin-luciferase were added. Light emission was recorded
precisely at 20 seconds with a Packard beta counter accepting
signals out of coincidence. Protein content was determined on a
portion of the cell sample and ATP was expressed as pmol/g cell
protein. To correct for the ATP content of the added neutrophils,
replicate PMN samples were run in 24 well plates without
mesothelial cells and the PMN ATP levels in concentration and
timed matched controls were subtracted from the experimental
samples. For example, PMNs accounted for approximately 17.9%
of the ATP content of a well when 400 d of 1250 PMN/mm3 were
added to a well; ATP levels of mesothelial cells were always
corrected for the number and state of activation in parallel
experiments using the same cohorts of mesothelial cells and
PMNs.
51Chromium release assay
Mesothelial cell cultures in 24 well plates were radiolabeled
overnight at 37°C in a 5% CO2 humidified incubator with 1
tCi/well 51chromium in complete media [23]. After labeling, the
monolayer was washed five times with 1 ml HEPES buffered
HBSS with 0.5% albumin. In time course experiments, five
mesothelial cell lines were exposed to 5000 PMNs/mm3 in HEPES
buffered HBSS with 0.5% albumin for one to five hours at 37°C.
In dose response experiments, five mesothelial cell cultures were
exposed to 1250, 2500, 3750, or 5000 PMNs/mm3 for five hours at
37°C. PMNs were activated with 50 ng/ml phorbol myristate
acetate (PMA); controls included mesothelial cells in buffer
alone, mesothelial cells exposed to PMA without PMNs, and
mesothelial cells exposed to PMNs without PMA. In some
experiments, mesothelial cell injury was determined when PMNs
were activated with iO FMLP/cytochalasin B. At the appropri-
ate time, the media were removed and the cells were washed once
with 0.5 ml HEPES buffered HBSS with 0,5% albumin. The
remaining intracellular label in each well was released by dissolv-
ing the cells in 400 d 2.0% Triton. All fractions were collected
and counted for two minutes in a Beckman gamma counter. The
percent release was calculated as (M + W)/(M + W + C) where
M represents the DPM in the media, W represents the DPM in
the wash, and C represents the DPM in the cell fraction [24]. The
51Cr release studies were always preformed on separate mesothe-
hal cell cohorts from the PMN adhesion studies in which the
PMNs were radiolabeled with 51Cr for determination of adher-
ence of PMNs to mesothehial cells.
Morphologic studies
Morphologic studies were preformed on mesothelial cells in
T25 flasks with a Zeiss TM 35 phase contrast microscope with cells
exposed to buffer alone, and in cells exposed to 1,250 activated
PMNs/ml or 3,750 activated PMNsImI for one to five hours.
Role of leukocyte adhesion molecules
Immunohistochemical studies were performed to determine if
mesothelial cells expressed ICAM-1 by using the murine anti-
ICAM-1 monoclonal antibody BBIG-I1 (#BBA3, R and D Sys-
tems, Minneapolis, Minnesota, USA). Immunocytochemistry was
performed on mesothelial cells grown on glass cover slips using
the alkaline phosphatase-anti-alkaline phosphatase technique
(Dako Corp., Carpinteria, California, USA) [25]. Mouse IgG and
a murine monoclonal antibody against E-selectin (another adhe-
sion molecule found on endothelial cells, clone BBIG-E6, BBA1,
R and D Systems) were used as negative controls.
To determine the role of leukocyte adhesion molecules in
mediating PMN adhesion and PMN induced mesothelial cell
injury, we determined PMN adhesion, ATP levels, and 5Cr
release with PMNs that were preincubated for 10 minutes with the
murine monoclonal antibody R15.7 (20 jg/ml final concentration)
that recognizes and inhibits CD18. PMN adhesion, ATP levels,
and 51Cr release were also determined with mesothelial cells that
were preincubated with the murine monoclonal anti-ICAM-1
(R6.5) and Fab fragments of monoclonal anti-ICAM R6.5 at a
final concentration of 20—50 jg/ml. PMN adhesion, ATP levels
and 51Cr release were determined as described above.
Statistical analysis
Data are presented as mean 1 SD. Students t-test was used
when comparing data in the PMN adhesion experiments. One way
analysis of variance with Tukey's multiple comparison procedure
was used to detect differences in ATP levels and 51Cr release in
the time course and dose response experiments. One way analysis
of variance with Fisher's Protected Least Significance Difference
was used to detect differences in ATP depletion and 51Cr release
when PMNs were preincubated with anti-adhesion molecule
monoclonal antibodies and in detecting differences in ATP deple-
tion and 51Cr release with bacteria and mesothelial cells.
Results
Mesothelial cell cultures
As shown in Figure 1A, mesothelial cells obtained from human
omentum demonstrated the typical polygonal appearance de-
scribed for such cells [12, 13]. Immunofluorescent studies dem-
onstrated that mesothelial cells stained positively for cytokeratin
(Fig. 2A) and vimentin (Fig. 2B) and were negative for desmin
(not shown) and Factor VIII related antigen (Fig. 2C). For
comparison, a positive endothelial stain for Factor VIII related
antigen is shown (Fig. 2D). In cells obtained from omentum, this
staining pattern has been found to be specific for mesothehial cells
[12, 13].
PMN adhesion
Preliminary studies demonstrated that PMN adherence was
maximal at 15 minutes, changed little from 15 minutes to two
hours, and slightly declined over the next three hours (data not
shown). Thus, PMN adherence was quantitated at 15 minutes in
the remainder of the studies. In each of the mesothelial cells
cultures, PMN adherence was significantly (P < 0.001) increased
when PMNs were activated compared to non-activated PMNs
(Fig. 3). When activated, 64.0 1.0 to 92.5 7.0% of the added
PMNS were adherent to the mesothelial cells compared to 6.0
1.8% to 27 2.4% of non-activated PMNs adhering to the
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Fig. 1. Morphologic alterations in normal mesothelial cells and in mesothelial cells exposed to activated PMNs. Mesothelial cells obtained from human
omentum demonstrated the typical polygonal appearance described for such cells (A). Mesothelial cells in control buffer continued to demonstrate
normal morphology while mesothelial cells exposed to 1250 activated PMNs/mm3 demonstrated morphologic alterations including retraction and gap
formation at 2 hours (B) which became marked by 4 hours (C). Similar but more severe morphologic changes were seen in cells exposed to 3,750
activated PMNs/ml for 2 (D) or 4 hours (E).
Fig. 2. Immunofluorescent characteristics of cultured mesothelial cells. Immunofluorescent studies demonstrated that mesothelial cells stained positively
for cytokeratin (A) and vimentin (B) and were negative for desmin (not shown) and Factor VIII related antigen (C). For comparison, a positive
endothelial stain for Factor VIII related antigen is shown (D).
mesothelial cells. When PMNs were activated with iO— FMLP/ PMNs. These studies show that PMN adhesion is an early event
cytochalasin B, PMN adhesion was also increased to 40.6 7.5% preceding the development of mesothelial cell injury.
to 64.0 4.4% compared to 9.5 0.9 to 10.4 2.3% in
non-activated PMNs. In preliminary studies, adhesion of PMNs PMN mediated mesothelial cell infuiy
treated with 5 j.tg/ml of cytochalasin-B without FMLP did not As shown in Figure 4, five different mesothelial cell lines
demonstrate increased adhesion compared to unstimulated responded to PMN mediated injury with a fall in ATP levels that
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Fig. 3. Adhesion of activated and non-activated PMNs to mesothelial cells.
Four hundred .diter of activated or non-activated PMNs at a concentra- 20
tion of 5000/mm3 were added to mesothelial cell monolayers in 24 well
cultures plates. When activated, PMNs adhered to five different mesothe-
hal cell cultures significantly (P < 0.001) more than non-activated PMNs. 0
When PMNs were activated with PMA, 64.0 1.0 to 92,5 7.0% of the
added PMNs were adherent to the mesothelial cells compared to 6.0
1.8% to 27 2.4% of non-activated PMNs adhering to the mesothelial
cells. Each value represents the mean 1 SD of 4 replicates. Symbols are: # PMNS/flhI
(U) PMNS; () PMNS + PMA. Fig. 5. Alterations in mesothelial ceIIATP levels in cells exposed toO to 5000
activated PMNs/mm3 for 5 hours. Mild ATP depletion was significant (P <
0.05) at 1250 activated PMNs/mm3 in 4 of the 5 cell lines while severe,
significant (P < 0.05) ATP depletion occurred at the higher PMN
I concentrations in each mesothelial cell line. ATP levels in mesothelial
cells exposed to HBSS without PMNs or PMA, PMNs without activation
with PMA, and PMA without PMNs remained greater than 92% of
I VU control. ATP in control mesothehial cells in the five cell lines ranged from
8,7 to 12.2 pmol/mg cell protein. Each value represents the mean of 4
1 SD of 4 replicates. Symbols are as in Figure 4.
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Fig. 4. Alterations in mesothelial cell A TP levels cells exposed to activated
PMNs for I to 5 hours. Five different mesothelial cell lines responded to
PMN mediated injury with a fall in ATP levels that was significant (P <
0.05) in 4 of the 5 cell lines at 3 hours and in all 5 cell lines at 4 hours. At
5 hours, ATP levels were markedly depressed to 5 to 41% of control
values. ATP levels in control mesothelial cells exposed to HEPES buffered
HBSS without PMNs or PMA, PMNs without PMA, or PMA without
PMNs remained greater than 92% control values. Each value represents
the mean 1 so of 4 replicates. Symbols are: (U) mesothehial #1; (0)
mesothehial #2; (•) mesothelial#3; (0) mesothelial #4; ()mesothehial
#5.
In dose response experiments, mild ATP depletion was significant
(P < 0.05) at the lowest PMN concentration in four of the five cell
lines while severe, significant (P < 0.05) ATP depletion occurred
at the higher PMN concentrations (Fig. 5). ATP levels in me-
sothelial cells exposed to HBSS without PMNs or PMA, PMNs
without activation with PMA, and PMA without PMNs remained
greater than 92% of control. ATP in control mesothelial cells in
the five cell lines ranged from 8.7 to 12.2 nmollmg cell protein.
When mesothelial cells were exposed to 5,000 PMNs/mm3 acti-
vated with iO FMLP!cytochalasin B for five hours, mesothelial
T' h cell ATP levels were 6.68 0.8 nmol/mg protein compared to 10.5me, ours 0.2 nmol/mg protein in control cells (P < 0.05); ATP levels in
mesothelial cells exposed to FMLP/cytochalasin-B without PMNs
were 9.7 0.4 nmol/mg cell protein and 9.6 0.4 nmol/mg
protein in mesothelial cells exposed to unstimulated PMNs. In
preliminary experiments, ATP levels in mesothelial cells treated
with 5 xg/ml cytochalasin-B without FMLP or iQ FMLP
without cytochalasin-B were similar to control mesothehial cells.
When 51Cr release was used to determine cell detachment and
lysis in mesothelial cells exposed to 5000 activated PMNs!mm3,
51Cr release was significant (P < 0.05) in four of the five cell lines
at two hours and in all cells lines by three hours (Fig. 6). 51Cr
release in mesothelial cells exposed to HEPES buffered HBSS
alone, PMNs without PMA, or PMA without PMNs, was less than
12%. When mesothelial cells were exposed to 1250, 2500, 3750,
and 5000 PMNs/mm3 activated with PMA, 51Cr release was
significant (P < 0.05) at 1250 PMNs/mm3 in three of the five cell
lines and at 2500 activated PMNs/mm3 in four of the five cell lines
(Fig. 7). At 5000 activated PMNs/mm3, 51Cr release was marked
was significant (P < 0.05) in four of the five cell lines at three
hours and in all five cell lines at four hours. At five hours, ATP
levels were markedly depressed to 5 to 41% of control values.
ATP levels in control mesothelial cells exposed to HEPES
buffered HBSS without PMNs or PMA, PMNs without PMA, or
PMA without PMNs remained greater than 92% control values.
Andreoli et al: PMN-mediated mesothelial cell injuly 1105
Time, hours
Fig. 6. 51Cr release in mesothelial cells exposed to activated PMNs for 0 to
5 hours. When 51Cr release was used to determine cell detachment and cell
lysis in mesothelial cells exposed to 5000 activated PMNs/mm3, 51Cr
release was significant (P < 0.05) in 4 of the 5 cell lines at 2 hours and in
all cell lines by 3 hours. 51Cr release in mesothelial cell exposed to HEPES
buffered HBSS alone, PMNs without PMA, or PMA without PMNs was
less than 12%. Each value represents the mean 1 SD of 4 replicates.
Symbols are as in Figure 4.
in all mesothelial cell lines. 51Cr release in mesothelial cells
exposed to HBSS without PMNs or PMA, PMNs without PMA, or
PMA without PMNs, was less than 7% to 12% after a five hour
incubation in the five cell lines, while 51Cr release in control cells
was considerably less at earlier time points. When mesothelial
cells were exposed to 5,000 PMNsJmm3 activated with FMLP/
cytochalasin-B for five hours, 51Cr release was 33.2 2.0%
compared to 12.1 1.6% in control cells (P < 0.05), 19.0 1.8%
in cells exposed to resting PMNs, and 13.4 1.9% in mesothelial
cells exposed to iO FMLP/cytochalasin-B without PMNs.
Morphologic studies showed that mesothelial cells in control
buffer continued to demonstrate normal morphology for the
duration of the studies while morphologic alterations including
retraction and gap formation were apparent in mesothelial cells
exposed to 1250 activated PMNs/ml for two hours (Fig. 1B) and
four hours (Fig. 1C). Similar but more severe morphologic
changes were seen in cells exposed to 3750 activated PMNs/ml for
two (Fig. 1D) or four hours (Fig. 1E). By four to five hours, the
monolayer was markedly distorted, clearly demonstrating that
mesothelial cells are susceptible to PMN mediated oxidant injury.
Role of adhesion molecules
Immunohistochemical staining showed that ICAM-1 was ex-
pressed by cultured mesothelial cells. No staining occurred when
the anti-ICAM antibody was replaced by either anti-E-selectin
monoclonal antibody or mouse IgG (Fig. 8).
The monoclonal anti-CD18 antibody provided significant (P <
0.01) partial protection of PMN mediated mesothelial cell ATP
depletion and 51Cr release in association with significant (P <
0.01) inhibition of PMN adhesion (Table 1). When mesothelial
cells were exposed to PMA activated PMNs, ATP levels were
reduced to 4.8 1.0 nmol/mg protein compared to 9.8 0.2
# PMNS/ml
Fig. 7. 51Chromium release when mesothelial cells were exposed to 0 to 5000
PMN/mm3 for 5 hours. When mesothelial cells were exposed to 1250, 2500,
3750, and 5000 PMNs/mm3 activated with PMA, 51Cr release was signif-
icant (P < 0.05) at 1250 PMNs/mm3 in three of the five cell lines and at
2500 activated PMNs/mm3 in four of the five cell lines (Fig. 6). At 5000
activated PMNs/mm3, 51Cr release was marked in all mesothelial cell lines.
51Cr release in mesothelial cells exposed to HBSS without PMNs or PMA,
PMNs without PMA or PMA without PMNs was less than 10%. Each
value represents the mean 1 SD of 4 replicates. Symbols are as in Figure
4.
nmollmg protein in control cells while ATP levels in mesothelial
cells exposed to PMA activated PMNs that were preincubated
with the anti-CD18 antibody were 8.0 0,3 nmol/mg protein.
Similar results were seen with PMN mediated 51Cr release (Table
1). Interestingly, protection from ATP depletion and 51Cr release
was associated with significantly (P < 0.001) reduced PMN
adhesion to mesothelial cell, Similar protection from injury and
decreased PMN adhesion was observed when PMNs were acti-
vated with FMLP/cytochalasin-B (Table 1). These studies dem-
onstrate the critical role for CD11/CD18 in mediating adhesion of
PMNs and subsequent PMN induced mesothelial cell injury.
Monoclonal anti-ICAM-1 antibodies, when used as a whole
molecule, actually increased the binding of nonactivated PMNs to
mesothelial cells (data not shown). However, when monoclonal
anti-ICAM-1 Fab fragments were used, the unstimulated PMN
adhesion was reduced, suggesting that mouse Fe-human FC
receptor interactions were occurring with the intact molecule.
Monoclonal anti-ICAM-1 Fab fragments only partially prevented
adhesion of activated PMNs to mesothelial cells and slightly
prevented ATP depletion and 51Cr release (Table 1). PMN
adhesion, ATP depletion and 51Cr release were minimally altered
when the concentration of anti-ICAM Fab was increased to 50
g/ml. Similar studies with FMLP/cytochalasin B activated PMNs
were not preformed due the scarcity of ICAM-1 FAB fragments.
Bacteria induced mesothelial cell injuly
When Staphylococcus aureus, Staphylococcus epidermidis, al-
pha streptococci, or Pseudomonas aeruginosa (four bacteria
commonly causing peritonitis) were incubated with mesothelial
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Fig. 8. Immunohistochemical staining of mesothelial cells for ICAM-1. Immunohistochemical staining demonstrating that cultured mesothelial cells
express ICAM-1. No staining occurred when the anti-ICAM antibody was replaced by either anti-E-selectin monoclonal antibody or mouse IgG (insert).
cells at concentrations of approximately i03, i04, and io bacte-
ria/mi for five hours, ATP levels and 51Cr release were not
significantly changed from control except for mild A1'P depletion
with the highest concentration of Pseudomonas aeruginosa and
slight 51Cr release with the higher concentrations of Pseudomonas
aeruginosa (Table 2).
Discussion
During the past several years, research has focused on the role
of oxidant injury in the pathophysiology of several diseases,
including many inflammatory and infectious diseases mediated by
activated PMNs [26]. Permanent sequela from infections such as
pyelonephritis have been shown to be mediated by the inflamma-
tory response from infiltrating PMNs rather than the multiplica-
tion or presence of bacteria [27, 28]. In other studies, anti-
inflammatory therapy such as intravenous steroids has also been
shown to decrease the sequela of bacterial infections such as
meningitis [29, 30]. During peritonitis, mesothelial cells on the
peritoneal membrane are subjected to an intense inflammatory
response. Previous studies have shown that PMNs obtained from
dialysate from patients with peritonitis are capable of generating
reactive oxygen molecules [15]. In addition, a recently published
study suggests that oxidants are present and are likely to be
mediators of injury during episodes of peritonitis in humans [31].
Alpha-1-proteinase inhibitor in peritoneal dialysate from patients
with peritonitis was oxidatively inactivated while alpha-i-protein-
ase inhibitor in dialysate from non-infected patients was normally
active [31]. The loss of normal alpha-1-proteinase inhibitor activ-
ity correlated with the peritoneal dialysate leukocyte count. This
strongly suggests that oxidant stress is occurring during peritonitis.
Our studies with human mesothelial cells clearly demonstrate
that mesothelial cells are susceptible to injury mediated by
activated PMNs. Activated PMNs adhered to mesothelial cells
with resultant injury as manifested by ATP depletion, 51Cr
release, and morphologic alterations. Within 15 minutes of acti-
vation, PMN adhesion to mesothelial cells was maximal; by one to
three hours ATP depletion was apparent, and by five hours ATP
depletion was severe. In addition, mesothelial cells exposed to
activated PMNs underwent cell detachment and lytic injury as
demonstrated by 51Cr release. Our studies demonstrate that
mesothelial cell injury occurred when PMNs were activated by two
different stimuli including FMLP/cytochalasin-B and PMA. Me-
sothelial cell injury was observed at concentrations of PMNs
commonly observed during peritonitis in humans. Activated
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Table 1. ATP levels, 51Chromium release, and PMN adhesion in
mesothelial cells exposed to 5,000 PMNs activated with io FMLP/
cytochalasin-B or 50 ng/ml PMA when PMNs were preincubated with
20 ng/ml anti-CD18 monoclonal antibodies or when mesothelial cells
were preincubated with 20 Wml anti-ICAM Fab fragments
ATP levels
nmol/mg
protein
51Cr
release
%
PMN
adhesion
% added
PMNs
Control
PMNs
PMNs + anti-CD18
PMNs + FMLP/cyto-B
PMNs + FMLP/cyto-B + anti-
CD18
10.4 0.3
9.9 0.5
10.2 0.5
7.8 0.7
9.7 0.6a
12.1 1.6
20.0 1.8
19.6 1.5
33.2 2.0
23.7 1.6
9.5 0.9
6.7 1.2
64.0 4.4
5.4 0.6
Control
PMNs
PMNs + anti-CD18
PMNs ÷ PMA
PMNs + PMA + anti-CD18
9.8 0.2
9.7 0.5
10.2 0.6
4.8 1.0
8.0 Q•3
7.1 0.4
6.5 0.6
6.7 1.0
43.7 6.4
25.2 4.1
11.6 1.2
3.6 0.6
90.9 2.2
15.1 2.6a
Control
PMNs
PMNs + anti-ICAM Fab
PMNs + PMA
PMNs + anti-ICAM Fab + PMA
9.7 0.2
9.5 0.3
9.6 0.5
6.1 0.5
7.3 0.9
13.0 1.9
16.3 1.5
16.3 1.5
34.7 1.8
31.6 4.3
10.1 0.1
6.3 0.3
79.4 3.2
48.7 8.4
When activated PMNs were preincubated with the anti-CD18 mono-
clonal antibody, ATP depletion and 51Cr release were each significantly (P
< 0.01) reduced compared to values obtained with activated PMNs. In
addition, the anti-CD18 monoclonal antibody also significantly (P < 0.01)
reduced PMN adhesion to mesothelial cells. Each value represents the
mean 1 SD.
a Denotes significantly different from activated PMNs not preincubated
with anti-CD18 monoclonal antibody.
PMNs also induced substantial morphologic alterations in me-
sothelial cells including retraction, gap formation and detach-
ment. Interestingly, similar morphologic alterations in mesothelial
cells have been observed in animal models of peritonitis and after
peritonitis in humans [2, 32, 331.
Previous studies have demonstrated that concentrations of
bacteria in dialysate during peritonitis are generally quite low,
ranging from 10 colony forming units to i03 colony forming units
per 100 ml of dialysate [181. In contrast to the studies with
activated PMNs, alterations in mesothelial cell ATP levels or 51Cr
release were not observed at bacterial concentrations that have
been reported to occur during peritonitis. Pseudomonas aerugi-
nosa at substantially higher concentrations did result in slight ATP
depletion and moderate 51Cr release compared to control me-
sothelial cells. Pseudomonas aeruginosa can release proteolytic
enzymes that cause cellular injury [34]. In addition, Pseudomonas
can release iron acquiring enzymes that help to create an envi-
ronment favorable for the generation of reactive oxygen mole-
cules [351. Thus, infections mediated by Pseudomonas may be
particularly harmful. Interestingly, peritonitis caused by Pseudo-
monas organisms is well-known to be difficult to eradicate and has
also been associated with peritoneal membrane injury [36—38].
Recently, several very interesting studies have demonstrated a
critical role for PMN adhesion in the inflammatory process
[21—23]. PMN adhesion is mediated by a group of leukocyte
adhesion molecules that are regulated and modulated by several
cytokines including tumor necrosis factor and interleukin-1 [21—
23, 39]. Increased PMN adhesion to endothelial cells has been
Table 2. ATP levels and 51Cr release in control mesothelial cells and
mesothelial cells exposed to 1 x io to 1 X iO colonies/mi
Staphylococcus aureas, Staphylococcus epidermidis, Alpha streptococci,
or Pseudomonas aureginosa for 5 hours
ATP levels
nmol/mg protein
51Cr release
%
Control 10.5 0.5 15.0 3.7
Staphylococcus aureus1— 2x io 10.0±0.1 15.3± 1.7
1— 2x io 11.0±0.3 15.6± 1.3
1 — 2 x i05 10.4 0.3 18.6 3.4
Staphylococcus epidermidis1 —2x iO 10.4±0.5 19.0±2.8
1 — 2 x iO 10.7 0.5 19.6 4.3
1 — 2 x io 10.4 0.3 19.0 2.5
Alpha streptococci
1 — 2 x io 11.1 0.2 20.7 1.9
1 — 2 x io 10.4 0.3 20.0 5.9
1 — 2 x i05 9.9 0.4 17.5 6.0
Pseudomonas aureginosa
1 — 2 x io 10.3 0.3 22.0 3.9
1 — 2 x i04 9.8 0.2 23.5 2.2a
1 — 2 x i05 8.6 0.9 35.0 7.1
Each value represents the mean of 4 replicates 1 SD.
a Denotes significantly (P < 0.05) less than control.
shown to be associated with PMN mediated endothelial cell injury
[39]. Conversely, mesangial cell injury by activated PMNs can be
reduced by blocking antibodies to leukocyte adhesion molecules
[40]. Our studies demonstrate that PMN-induced mesothelial cell
injury is associated with PMN adhesion and that this injury can be
prevented by blocking the CD11/CD18 adhesion molecule com-
plex located on activated PMNs. One ligand for CD11/CD18
mediated adhesion is through ICAM-1, located on mesothelial
cells as well as endothelial cells. However, our studies also clearly
show that there is CD11/CD18 dependent, ICAM-1 independent
interaction between PMNs and mesothelial cells.
Several in vivo studies suggest that oxidants are generated and
may be mediators of injury during peritonitis in humans [15, 31].
In addition, several mediators of the inflammatory response
including TNF, PAF, IL-6 and IL-8 levels are dramatically
increased in dialysate during episodes of peritonitis while others
studies have demonstrated free intraperitoneal elastase during
peritonitis [41—431. Interestingly, Topley et al have demonstrated
that IL-6 and IL-8 are produced by mesothelial cells in response
to TNF and IL-i [44—46]. These in vivo studies, together with in
vitro studies, suggest that the inflammatory environment gener-
ated by activated PMNs is responsible for the acute alterations in
peritoneal membrane function during peritonitis in vivo. In vivo,
such alterations are usually reversible with a return of normal
membrane function over days to weeks. However, repeated
episodes of peritonitis may lead to irreversible alterations in
membrane function. According to some investigators, frequent
episodes of peritonitis are a risk factor associated with irreversible
membrane injury [47—49]. We found that the incidence of mem-
brane failure in children undergoing long-term dialysis increased
with the duration of peritoneal dialysis and was related to
episodes of peritonitis, particularly peritonitis caused by Pseudo-
monas and alpha streptococcal organisms [38]. We suggest that
recurrent episodes of peritonitis lead to irreversible mesothelial
cell injury that limits the long-term durability of the peritoneal
membrane.
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In summary, we conclude that activated PMNs adhere to
human mesothelial cells and initiate mesothelial cell injury as
manifested by ATP depletion, 51Cr release, and morphologic
alterations. Such injury can be substantially reduced by blocking
PMN adhesion to mesothelial cells with an anti-CD 18 monoclonal
antibody. Bacteria that commonly cause peritonitis had little to no
effect on ATP levels or 51Cr release. These results suggest that the
inflammatory response during peritonitis (rather than the pres-
ence and multiplication of bacteria) is a major determinant of
mesothelial cell injury and that such injury can be modified by
therapy to prevent PMN induced cell injury.
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